GoodCap Pharmaceuticals
Ken is gastroenterologist and internist at Mount Sinai Hospital in Toronto, Canada with 35+ years of experience in medical practice, teaching, and research focused on gut inflammation and health. He has worked extensively with the Crohn’s and Colitis Foundation of Canada where he helped to develop the IBD Research Institute, and is now a project leader of the GEM Project, a global clinical study coordinated out of the IBD research group at the Zane Cohen Centre at Mount Sinai Hospital. Ken is a full Professor of Medicine at the University of Toronto, where he is a member of the Institute of Medical Science and secondarily appointed to the Department of Immunology.
This person is not in the org chart
This person is not in any offices
GoodCap Pharmaceuticals
GoodCap Pharmaceuticals Inc. (goodcapwellness.com) is a leading Canadian drug development and retail experience company devoted to harnessing and applying the physical and mental health benefits of mushrooms and mushroom-derived compounds.